Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox follow-up study for chronic pelvic pain with pelvic floor muscle spasm
ACTRN12605000515695Phase 4Active, not recruiting
- Sponsor
- Allergan
- Start
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in chronic prostatitis (CP), sponsored by Allergan. Primary endpoints: Pain response, Quality of life response and 2 more. Started Apr 2005; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ACTRN12605000515695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000515695.